文献速递心脑血管急症

急诊科检测限试验(LEGEND):阶梯楔形整群随机试验用于排除急性心肌梗死并缩短急诊患者住院时间

The Limit of Detection in the Emergency Department Trial (LEGEND): A Stepped-Wedge Cluster Randomized Trial to Rule Out Acute Myocardial Infarction and Reduce Hospital Length of Stay for Patients Presenting to the Emergency Department.
PubMed 文献 · Ann Emerg Med · 2025-12-16
一句话结论LEGEND 排除策略将高敏肌钙蛋白浓度与共享决策结合,对疑似ACS且肌钙蛋白≤2 ng/L的急诊患者可安全排除心梗、缩短LOS 3.6小时、增加4小时内安全出院比例22.9%。

LEGEND 是一项在4个澳大利亚急诊科进行的阶梯楔形整群随机对照试验,2019年8月至2020年7月纳入9,944例疑似急性冠脉综合征的成年患者,其中标准治疗组5,347例、干预组4,597例。干预为实施LEGEND排除策略(高敏肌钙蛋白浓度结合共享决策)。对于LEGEND队列(就诊时肌钙蛋白≤2 ng/L)患者,干预组平均住院时间较标准治疗组缩短3.6小时(95%CI 2.5至4.6小时),4小时内安全出院比例增加22.9%(95%CI 19.5%至26.3%),心脏检查减少7.8%(95%CI 4.6%至11.1%)。再就诊、指数事件及30天事件无差异。结论认为LEGEND策略可安全排除急性心肌梗死、缩短住院时间、增加4小时内出院比例并减少心脏检查。

要点

  • 对疑似ACS且就诊时高敏肌钙蛋白≤2 ng/L的急诊患者,LEGEND策略组平均住院时间较标准治疗组缩短3.6小时(95%CI 2.5至4.6小时)。
  • LEGEND策略组4小时内安全出院比例较标准治疗组增加22.9%(95%CI 19.5%至26.3%)。
  • LEGEND策略组心脏检查较标准治疗组减少7.8%(95%CI 4.6%至11.1%)。
  • 两组再就诊、指数事件及30天事件无差异。
  • LEGEND策略整合高敏肌钙蛋白浓度与共享决策,用于急诊疑似ACS患者的快速排除评估。

适用人群与场景

  • 4个澳大利亚急诊科就诊的成年疑似急性冠脉综合征患者,共9,944例(标准治疗组5,347例,干预组4,597例)。
  • LEGEND队列为就诊时高敏肌钙蛋白≤2 ng/L的患者。

诊断标准与关键阈值

  • LEGEND排除策略整合高敏肌钙蛋白检测浓度与共享决策。
  • LEGEND队列定义为就诊时肌钙蛋白≤2 ng/L。

处置流程与药物剂量

  • 对疑似ACS患者实施LEGEND排除策略:整合高敏肌钙蛋白浓度与共享决策进行快速评估。

研究设计与关键结果

  • 研究类型为阶梯楔形整群随机对照试验,在4个澳大利亚急诊科进行,2019年8月至2020年7月纳入9,944例成年疑似ACS患者,标准治疗组5,347例、干预组4,597例。
  • 主要终点住院时间:LEGEND队列(就诊肌钙蛋白≤2 ng/L)干预组平均LOS较标准治疗组缩短3.6小时(95%CI 2.5至4.6小时)。
  • 次要终点4小时内安全出院比例:干预组较标准治疗组增加22.9%(95%CI 19.5%至26.3%)。
  • 次要终点心脏检查:干预组较标准治疗组减少7.8%(95%CI 4.6%至11.1%)。
  • 再就诊、指数事件及30天事件两组无差异。

证据类型、等级与局限

  • 证据类型:阶梯楔形整群随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对疑似ACS且就诊时高敏肌钙蛋白≤2 ng/L的急诊患者,实施LEGEND排除策略可缩短住院时间、增加4小时内安全出院比例并减少心脏检查,同时再就诊、指数事件及30天事件无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVES: The Limit of Detection in the Emergency Department (LEGEND) rule-out strategy integrates high-sensitivity cardiac troponin assay concentrations with shared decision making to rapidly assess emergency patients with suspected acute coronary syndrome (ACS). We hypothesized that the LEGEND rule-out strategy would reduce length of stay (LOS), increase the proportion of patients safely discharged within 4 hours, reduce cardiac testing, and decrease hospital representations, while maintaining patient safety.

METHODS: We conducted a stepped-wedge cluster randomized controlled trial in 4 Australian emergency departments from August 2019 to July 2020. We included adult patients presenting with suspected ACS. We randomized sites to implement the LEGEND strategy. The primary outcome was LOS. Secondary outcomes included discharge from hospital within 4 hours, cardiovascular tests, representations, index, and 30-day events.

RESULTS: The study included 9,944 patients, 5,347 in the standard care and 4,597 in the intervention arm. For patients in the LEGEND cohort (presentation troponin ≤2 ng/L), the mean LOS was 3.6 hours shorter in the intervention arm than the standard care arm (95% confidence interval [CI] 2.5 to 4.6 hours). The proportion of patients safely discharged within 4 hours increased by 22.9% (95% CI 19.5% to 26.3%), and cardiac testing decreased by 7.8% (95% CI 4.6% to 11.1%). There were no differences in representations, index events, or 30-day events.

CONCLUSION: The LEGEND rule-out strategy safely ruled out acute myocardial infarction, reduced hospital LOS, increased the proportion of patients discharged within 4 hours, and reduced cardiac testing.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Greenslade J, Parsonage W, Stephensen L, et al. The Limit of Detection in the Emergency Department Trial (LEGEND): A Stepped-Wedge Cluster Randomized Trial to Rule Out Acute Myocardial Infarction and Reduce Hospital Length of Stay for Patients Presenting to the Emergency Department. Ann Emerg Med. 2025. PMID: 41405523. doi:10.1016/j.annemergmed.2025.10.014

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。